{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:07:35Z","timestamp":1777622855388,"version":"3.51.4"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT2016-228 9"],"award-info":[{"award-number":["PICT2016-228 9"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT2017-4543"],"award-info":[{"award-number":["PICT2017-4543"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PIP0750"],"award-info":[{"award-number":["PIP0750"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejphar.2020.173724","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T02:29:32Z","timestamp":1604370572000},"page":"173724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["PDE5 inhibition improves cardiac morphology and function in SHR by reducing NHE1 activity: Repurposing Sildenafil for the treatment of hypertensive cardiac hypertrophy"],"prefix":"10.1016","volume":"891","author":[{"given":"Daiana S.","family":"Escudero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda S.","family":"Brea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia I.","family":"Caldiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda E.","family":"Amarillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge O.","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique L.","family":"Portiansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e9stor G.","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romina G.","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejphar.2020.173724_bib1","first-page":"667","article-title":"Effects of antihypertensive therapy on cardiac sodium\/hydrogen ion exchanger activity and hypertrophy in spontaneously hypertensive rats","volume":"18","author":"Alvarez","year":"2002","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ejphar.2020.173724_bib2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fphys.2013.00152","article-title":"Mitochondrial NHE1: a newly identified target to prevent heart disease","volume":"4","author":"Alvarez","year":"2013","journal-title":"Front. Physiol."},{"issue":"7","key":"10.1016\/j.ejphar.2020.173724_bib3","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1291\/hypres.31.1465","article-title":"Is cardiac hypertrophy in spontaneously hypertensive rats the cause or the consequence of oxidative stress?","volume":"31","author":"Alvarez","year":"2008","journal-title":"Hypertens. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2020.173724_bib4","doi-asserted-by":"crossref","first-page":"H144","DOI":"10.1152\/ajpheart.00522.2010","article-title":"Stress-induced opening of the permeability transition pore in the dystrophin-deficient heart is attenuated by acute treatment with sildenafil","volume":"300","author":"Ascah","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.ejphar.2020.173724_bib5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cardiores.2004.09.024","article-title":"Chronic inhibition of Na+\/H+-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure","volume":"65","author":"Baartscheer","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"12","key":"10.1016\/j.ejphar.2020.173724_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144737","article-title":"Impact of mitochondrial Ca2+-sensitive potassium (mBKCa) channels in sildenafil-induced cardioprotection in rats","volume":"10","author":"Behmenburg","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ejphar.2020.173724_bib7","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/01.hjh.0000358834.18311.fc","article-title":"Endothelial dysfunction in spontaneously hypertensive rats: focus on methodological aspects","volume":"27","author":"Bernatova","year":"2009","journal-title":"J. Hypertens. Suppl."},{"key":"10.1016\/j.ejphar.2020.173724_bib8","doi-asserted-by":"crossref","first-page":"113667","DOI":"10.1016\/j.bcp.2019.113667","article-title":"Silencing of epidermal growth factor receptor reduces Na(+)\/H(+) exchanger 1 activity and hypertensive cardiac hypertrophy","volume":"170","author":"Brea","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2020.173724_bib9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1152\/jappl.1973.34.2.279","article-title":"Validation in awake rats of a tail-cuff method for measuring systolic pressure","volume":"34","author":"Bunag","year":"1973","journal-title":"J. Appl. Physiol."},{"issue":"3","key":"10.1016\/j.ejphar.2020.173724_bib10","first-page":"257","article-title":"The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases","volume":"2014","author":"Butrous","year":"2014","journal-title":"Glob. Cardiol. Sci. Pract."},{"issue":"Pt 3","key":"10.1016\/j.ejphar.2020.173724_bib11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1113\/jphysiol.2007.141689","article-title":"Mitochondrial reactive oxygen species activate the slow force response to stretch in feline myocardium","volume":"584","author":"Caldiz","year":"2007","journal-title":"J. Physiol."},{"issue":"4","key":"10.1016\/j.ejphar.2020.173724_bib12","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0008-6363(01)00544-2","article-title":"Regression of cardiomyocyte hypertrophy in SHR following chronic inhibition of the Na(+)\/H(+) exchanger","volume":"53","author":"Camilion de Hurtado","year":"2002","journal-title":"Cardiovasc. Res."},{"issue":"7","key":"10.1016\/j.ejphar.2020.173724_bib13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/01.RES.0000016836.24179.AE","article-title":"Na(+)-H(+) exchanger inhibition: a new antihypertrophic tool","volume":"90","author":"Cingolani","year":"2002","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2020.173724_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/01.HYP.0000051502.93374.1C","article-title":"Regression of hypertensive myocardial fibrosis by Na(+)\/H(+) exchange inhibition","volume":"41","author":"Cingolani","year":"2003","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.ejphar.2020.173724_bib15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00424-011-1020-8","article-title":"In vivo key role of reactive oxygen species and NHE-1 activation in determining excessive cardiac hypertrophy","volume":"462","author":"Cingolani","year":"2011","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.ejphar.2020.173724_bib16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.dib.2016.02.056","article-title":"Data supporting the cardiac mitochondria calcium handling in female normotensive and spontaneously hypertensive rats","volume":"7","author":"Ciocci Pardo","year":"2016","journal-title":"Data Brief"},{"issue":"20","key":"10.1016\/j.ejphar.2020.173724_bib17","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1074\/jbc.274.20.13729","article-title":"Cyclic GMP phosphodiesterase-5: target of sildenafil","volume":"274","author":"Corbin","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ejphar.2020.173724_bib18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/dmrr.689","article-title":"Role of endothelin-1, sodium hydrogen exchanger-1 and mitogen activated protein kinase (MAPK) activation in glucose-induced cardiomyocyte hypertrophy","volume":"23","author":"Chen","year":"2007","journal-title":"Diabetes Metabol. Res. Rev."},{"issue":"5","key":"10.1016\/j.ejphar.2020.173724_bib19","doi-asserted-by":"crossref","first-page":"H1236","DOI":"10.1152\/ajpheart.00100.2009","article-title":"ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice","volume":"296","author":"Das","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2-3","key":"10.1016\/j.ejphar.2020.173724_bib20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0005-2728(99)00024-9","article-title":"Guanylate cyclase and the .NO\/cGMP signaling pathway","volume":"1411","author":"Denninger","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2020.173724_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2019.01.070","article-title":"p38 mitogen activated protein kinase mediates cardiac Na(+)\/H(+) exchanger inhibition induced by Sildenafil","volume":"849","author":"Diaz","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"4-5","key":"10.1016\/j.ejphar.2020.173724_bib22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1159\/000322321","article-title":"Phosphodiesterase 5A inhibition decreases NHE-1 activity without altering steady state pH(i): role of phosphatases","volume":"26","author":"Diaz","year":"2010","journal-title":"Cell. Physiol. Biochem."},{"issue":"11","key":"10.1016\/j.ejphar.2020.173724_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223914","article-title":"Sildenafil citrate long-term treatment effects on cardiovascular reactivity in a SHR experimental model of metabolic syndrome","volume":"14","author":"Doghri","year":"2019","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ejphar.2020.173724_bib24","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/01.RES.0000014966.97486.C0","article-title":"Inhibition of Na(+)-H(+) exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice","volume":"90","author":"Engelhardt","year":"2002","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.ejphar.2020.173724_bib25","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/01.HYP.0000071180.12012.6E","article-title":"Regression of isoproterenol-induced cardiac hypertrophy by Na+\/H+ exchanger inhibition","volume":"41","author":"Ennis","year":"2003","journal-title":"Hypertension"},{"issue":"1-3","key":"10.1016\/j.ejphar.2020.173724_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejphar.2006.04.039","article-title":"Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats","volume":"542","author":"Ferreira-Melo","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"19","key":"10.1016\/j.ejphar.2020.173724_bib27","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/CIRCULATIONAHA.104.523324","article-title":"Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy","volume":"112","author":"Fries","year":"2005","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.ejphar.2020.173724_bib28","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ejphar.2020.173724_bib29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4103\/0253-7613.132158","article-title":"Effect of preoperative oral sildenafil on severe pulmonary artery hypertension in patients undergoing mitral valve replacement","volume":"46","author":"Gandhi","year":"2014","journal-title":"Indian J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2020.173724_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000325201","article-title":"Myocardial reperfusion injury: reactive oxygen species vs. NHE-1 reactivation","volume":"27","author":"Garciarena","year":"2011","journal-title":"Cell. Physiol. Biochem."},{"issue":"9","key":"10.1016\/j.ejphar.2020.173724_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24091765","article-title":"Sodium-hydrogen exchanger isoform-1 inhibition: a promising pharmacological intervention for resuscitation from cardiac arrest","volume":"24","author":"Gazmuri","year":"2019","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.ejphar.2020.173724_bib32","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrd2030","article-title":"Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond","volume":"5","author":"Ghofrani","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2-3","key":"10.1016\/j.ejphar.2020.173724_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0167-5273(02)00421-7","article-title":"Coronary and systemic hemodynamic effects of sildenafil citrate: from basic science to clinical studies in patients with cardiovascular disease","volume":"86","author":"Gillies","year":"2002","journal-title":"Int. J. Cardiol."},{"issue":"20","key":"10.1016\/j.ejphar.2020.173724_bib34","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","article-title":"Oral sildenafil in the treatment of erectile dysfunction. Sildenafil study group","volume":"338","author":"Goldstein","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2020.173724_bib35","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1253\/jcj.54.535","article-title":"The role of Na+\/H+ exchange in norepinephrine-induced protein synthesis in neonatal cultured rat cardiomyocytes","volume":"54","author":"Hori","year":"1990","journal-title":"Jpn. Circ. J."},{"issue":"4","key":"10.1016\/j.ejphar.2020.173724_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/aps.2016.13","article-title":"Sildenafil ameliorates left ventricular T-tubule remodeling in a pressure overload-induced murine heart failure model","volume":"37","author":"Huang","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"issue":"5A","key":"10.1016\/j.ejphar.2020.173724_bib37","doi-asserted-by":"crossref","first-page":"13C","DOI":"10.1016\/S0002-9149(99)00043-0","article-title":"Effects of sildenafil citrate on human hemodynamics","volume":"83","author":"Jackson","year":"1999","journal-title":"Am. J. Cardiol."},{"issue":"3 Suppl. l","key":"10.1016\/j.ejphar.2020.173724_bib38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.urology.2006.05.047","article-title":"Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective","volume":"68","author":"Jackson","year":"2006","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.ejphar.2020.173724_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijcard.2004.09.002","article-title":"Safety and efficacy of Sildenafil therapy in children with pulmonary hypertension","volume":"100","author":"Karatza","year":"2005","journal-title":"Int. J. Cardiol."},{"issue":"8","key":"10.1016\/j.ejphar.2020.173724_bib40","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.bbamem.2010.05.005","article-title":"Sustained intracellular acidosis activates the myocardial Na(+)\/H(+) exchanger independent of amino acid Ser(703) and p90(rsk)","volume":"1798","author":"Karki","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.ejphar.2020.173724_bib41","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1517\/13543784.9.5.1099","article-title":"Pharmacology and clinical assessment of cariporide for the treatment coronary artery diseases","volume":"9","author":"Karmazyn","year":"2000","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejphar.2020.173724_bib42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yjmcc.2013.02.006","article-title":"NHE-1: still a viable therapeutic target","volume":"61","author":"Karmazyn","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"9","key":"10.1016\/j.ejphar.2020.173724_bib43","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/01.RES.85.9.777","article-title":"The myocardial Na(+)-H(+) exchange: structure, regulation, and its role in heart disease","volume":"85","author":"Karmazyn","year":"1999","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.ejphar.2020.173724_bib44","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/01.HYP.0000102863.23854.0B","article-title":"Aldosterone increases NHE-1 expression and induces NHE-1-dependent hypertrophy in neonatal rat ventricular myocytes","volume":"42","author":"Karmazyn","year":"2003","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.ejphar.2020.173724_bib45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1568006054553417","article-title":"The Na(+)\/H(+) exchanger: a target for cardiac therapeutic intervention","volume":"5","author":"Karmazyn","year":"2005","journal-title":"Curr. Drug Targets - Cardiovasc. Hematol. Disord."},{"issue":"11","key":"10.1016\/j.ejphar.2020.173724_bib46","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/CIRCULATIONAHA.111.065300","article-title":"Long-term effects of sildenafil in a rat model of chronic mitral regurgitation: benefits of ventricular remodeling and exercise capacity","volume":"125","author":"Kim","year":"2012","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ejphar.2020.173724_bib47","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/bph.13749","article-title":"Targeting phosphodiesterase 5 as a therapeutic option against myocardial ischaemia\/reperfusion injury and for treating heart failure","volume":"175","author":"Korkmaz-Icoz","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2020.173724_bib48","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00059-006-2819-5","article-title":"Ventricular hypertrophy and hypertension: prognostic elements and implications for management","volume":"31","author":"Krauser","year":"2006","journal-title":"Herz"},{"key":"10.1016\/j.ejphar.2020.173724_bib49","doi-asserted-by":"crossref","first-page":"106601","DOI":"10.1016\/j.vph.2019.106601","article-title":"Sildenafil reduces aortic endothelial dysfunction and structural damage in spontaneously hypertensive rats: role of NO, NADPH and COX-1 pathways","volume":"124","author":"Leal","year":"2020","journal-title":"Vasc. Pharmacol."},{"issue":"20","key":"10.1016\/j.ejphar.2020.173724_bib50","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1053\/euhj.2000.2339","article-title":"Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'?","volume":"21","author":"Lip","year":"2000","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2020.173724_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexmp.2019.01.007","article-title":"Silencing of the Na(+)\/H(+) exchanger 1(NHE-1) prevents cardiac structural and functional remodeling induced by angiotensin II","volume":"107","author":"Medina","year":"2019","journal-title":"Exp. Mol. Pathol."},{"issue":"4","key":"10.1016\/j.ejphar.2020.173724_bib52","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.athoracsur.2007.10.054","article-title":"Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study","volume":"85","author":"Mentzer","year":"2008","journal-title":"Ann. Thorac. Surg."},{"issue":"19","key":"10.1016\/j.ejphar.2020.173724_bib53","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMsa063904","article-title":"Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development","volume":"355","author":"Murad","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ejphar.2020.173724_bib54","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/CIRCRESAHA.108.189050","article-title":"Regulation of intracellular and mitochondrial sodium in health and disease","volume":"104","author":"Murphy","year":"2009","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2020.173724_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.ejphar.2020.173724_bib56","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jacc.2008.08.069","article-title":"Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload","volume":"53","author":"Nagayama","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.ejphar.2020.173724_bib57","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1152\/japplphysiol.00996.2014","article-title":"Cardiac hypertrophy reduction in SHR by specific silencing of myocardial Na(+)\/H(+) exchanger","volume":"118","author":"Nolly","year":"2015","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2020.173724_bib58","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3332\/ecancer.2018.824","article-title":"Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents","volume":"12","author":"Pantziarka","year":"2018","journal-title":"Ecancermedicalscience"},{"issue":"6","key":"10.1016\/j.ejphar.2020.173724_bib59","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/01.RES.77.6.1192","article-title":"pHi regulation in myocardium of the spontaneously hypertensive rat. Compensated enhanced activity of the Na(+)-H+ exchanger","volume":"77","author":"Perez","year":"1995","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2020.173724_bib60","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1161\/HYPERTENSIONAHA.107.087759","article-title":"Phosphodiesterase 5A inhibition induces Na+\/H+ exchanger blockade and protection against myocardial infarction","volume":"49","author":"Perez","year":"2007","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.ejphar.2020.173724_bib61","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/CIRCULATIONAHA.108.822072","article-title":"Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice","volume":"119","author":"Pokreisz","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ejphar.2020.173724_bib62","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/vr.150.2.42","article-title":"Collagenous and elastic system fibres in the aorta of cattle poisoned by Solanum glaucophyllum","volume":"150","author":"Portiansky","year":"2002","journal-title":"Vet. Rec."},{"issue":"1-2","key":"10.1016\/j.ejphar.2020.173724_bib63","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11010-011-0711-y","article-title":"Temporal relation of cardiac hypertrophy, oxidative stress, and fatty acid metabolism in spontaneously hypertensive rat","volume":"351","author":"Purushothaman","year":"2011","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.ejphar.2020.173724_bib64","doi-asserted-by":"crossref","first-page":"H598","DOI":"10.1152\/ajpheart.00198.2002","article-title":"H(2)O(2)-induced Ca(2+) overload in NRVM involves ERK1\/2 MAP kinases: role for an NHE-1-dependent pathway","volume":"283","author":"Rothstein","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.ejphar.2020.173724_bib65","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ajh.2008.16","article-title":"Left ventricular hypertrophy and clinical outcomes in hypertensive patients","volume":"21","author":"Ruilope","year":"2008","journal-title":"Am. J. Hypertens."},{"issue":"10","key":"10.1016\/j.ejphar.2020.173724_bib66","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.RES.82.10.1053","article-title":"Hydrogen peroxide activates mitogen-activated protein kinases and Na+-H+ exchange in neonatal rat cardiac myocytes","volume":"82","author":"Sabri","year":"1998","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2020.173724_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019922","article-title":"Differential regulation of PDE5 expression in left and right ventricles of feline hypertrophy models","volume":"6","author":"Shan","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ejphar.2020.173724_bib68","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1472-8206.2005.00345.x","article-title":"Effect of sildenafil on the isolated rat aortic rings","volume":"19","author":"Sharabi","year":"2005","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejphar.2020.173724_bib69","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jtcvs.2006.08.035","article-title":"Effect of oral sildenafil citrate on intraoperative hemodynamics in patients with pulmonary hypertension undergoing valvular heart surgery","volume":"132","author":"Shim","year":"2006","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"2","key":"10.1016\/j.ejphar.2020.173724_bib70","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.ejphar.2020.173724_bib71","doi-asserted-by":"crossref","first-page":"H1237","DOI":"10.1152\/ajpheart.00840.2010","article-title":"Silencing of cardiac mitochondrial NHE1 prevents mitochondrial permeability transition pore opening","volume":"300","author":"Villa-Abrille","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2020.173724_bib72","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.mex.2015.02.007","article-title":"Determination of collagen content within picrosirius red stained paraffin-embedded tissue sections using fluorescence microscopy","volume":"2","author":"Vogel","year":"2015","journal-title":"MethodsX"},{"issue":"6","key":"10.1016\/j.ejphar.2020.173724_bib73","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1073\/pnas.89.6.2424","article-title":"The Na+\/H+ antiporter cytoplasmic domain mediates growth factor signals and controls \"H(+)-sensing","volume":"89","author":"Wakabayashi","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.ejphar.2020.173724_bib74","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/004982599238687","article-title":"Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man","volume":"29","author":"Walker","year":"1999","journal-title":"Xenobiotica"},{"issue":"5A","key":"10.1016\/j.ejphar.2020.173724_bib75","doi-asserted-by":"crossref","first-page":"21C","DOI":"10.1016\/S0002-9149(99)00044-2","article-title":"Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist","volume":"83","author":"Webb","year":"1999","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.ejphar.2020.173724_bib76","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00395-012-0308-y","article-title":"Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo","volume":"107","author":"Westermann","year":"2012","journal-title":"Basic Res. Cardiol."},{"issue":"3","key":"10.1016\/j.ejphar.2020.173724_bib77","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/CIRCRESAHA.110.228437","article-title":"Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98\/let-7","volume":"108","author":"Yang","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2020.173724_bib78","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.yjmcc.2014.09.004","article-title":"Physiological cardiac hypertrophy: critical role of AKT in the prevention of NHE-1 hyperactivity","volume":"76","author":"Yeves","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.ejphar.2020.173724_bib79","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0735-1097(00)00730-0","article-title":"Sarcolemmal Na+\/H+ exchanger activity and expression in human ventricular myocardium","volume":"36","author":"Yokoyama","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ejphar.2020.173724_bib80","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0735-1097(01)01608-4","article-title":"The Na(+)\/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial","volume":"38","author":"Zeymer","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2020.173724_bib81","doi-asserted-by":"crossref","first-page":"113818","DOI":"10.1016\/j.bcp.2020.113818","article-title":"Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease","author":"Zuccarello","year":"2020","journal-title":"Biochem. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920308165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920308165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:29:27Z","timestamp":1777415367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920308165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":81,"alternative-id":["S0014299920308165"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173724","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PDE5 inhibition improves cardiac morphology and function in SHR by reducing NHE1 activity: Repurposing Sildenafil for the treatment of hypertensive cardiac hypertrophy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173724","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173724"}}